Wellinks
PrivateLast Round
Series B
Aug 4, 2026
Total Funding Raised
$51.57M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Wellinks operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Series B round in August 2026.
Wellinks is a digital health company that provides a virtual-first cardiopulmonary care platform combining remote patient monitoring technology with personalized clinical coaching to manage chronic respiratory conditions like COPD.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Health IoT, Medical Devices, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wellinks Comparables
Compare Wellinks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keva Health | 84% | |
| VitalFlo | 83% | |
| RecoveryPlus Health | 83% |
For institutional investors. Book with your work email.
Wellinks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 4, 2026 | ||||
| Seed Round | Feb 13, 2026 | ||||
| Private Placement | Nov 17, 2025 | ||||
| M&A | Sep 30, 2024 | ||||
| Series C | Nov 3, 2021 | ||||
M&A | Jan 6, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wellinks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series C, Seed, Series A, Series B, VC Round |
| HighCape Capital | Series B, Series C |
| Benslie Investment Group | Series C, VC Round |
| Morningside Ventures | Series C |
| Gilde Healthcare | M&A |
| Simon School Venture Fund | Series C |
| Stonehenge Growth Capital | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2026
$10M round with UMass Memorial Health participating.
- Nov 17, 2025
Raised $6M in a private placement round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 31, 2026
Wellinks promotes Andrew Brimer to Vice President of Technology, where he leads Technology and advances development of its integrated cardiopulmonary care solution.
- hiresAug 31, 2026
In Aug '26, Wellinks appoints Stephanie Solich as Vice President of Customer Success, where she leads the customer success strategy and supports clients with implementation, collaboration, and long-term program value.
- hiresAug 31, 2026
Wellinks appoints Stephanie Willard, MHA, RRT-NPS, as Vice President of Clinical Operations as part of three new leadership appointments in Connecticut on Aug 31st '26.
For institutional investors. Book with your work email.
Wellinks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wellinks's valuation, stock price, and market status.
Is Wellinks a public or private company?
Wellinks is a private company.
What is the current stock price of Wellinks?
Wellinks is a private company, so its shares have no public market price. Caplight tracks Wellinks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wellinks worth (valuation)?
Valuation information for Wellinks is not publicly available.
Can I buy Wellinks stock?
Wellinks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wellinks's last funding round?
Wellinks's most recent funding round was Series B on August 4, 2026.
Who are the main investors in Wellinks?
Key investors in Wellinks include Connecticut Innovations, HighCape Capital, Benslie Investment Group, Morningside Ventures, Stonehenge Growth Capital.
Will Wellinks IPO soon?
No public IPO plans have been announced for Wellinks.
How can I track Wellinks secondary market activity?
Caplight tracks bids, offers, and trades in Wellinks's shares on secondary markets.